drug
belatacept
Marketedupdated 3mo agoby Bristol-Myers Squibb Co
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying belatacept
- phase2Carfilzomib and Belatacept for Desensitization
- phase1Tolerance by Engaging Antigen During Cellular Homeostasis
- phase3A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
- phase2Daratumumab and Belatacept for Desensitization
- phase2A Study of TCD601 in de Novo Renal Transplant Recipients
- phase4Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression
- phase2The Safety/Efficacy Of Daratumumab With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation
- phase2Belatacept in De Novo Heart Transplantation
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 48m ago
Found something off?
comments(0)
5-min edit window · permanent after that